Research programme: topical microbicides - Osel
Latest Information Update: 22 Jul 2011
At a glance
- Originator Osel Inc
- Mechanism of Action HIV fusion inhibitors; Virus attachment inhibitors
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Preclinical Bacterial vaginosis; HIV infections
Most Recent Events
- 22 Jul 2011 Preclinical development is ongoing USA